Published in Int J Dermatol on October 01, 1994
Antifungal agents for common paediatric infections. Can J Infect Dis Med Microbiol (2008) 0.93
Management of tinea capitis in childhood. Clin Cosmet Investig Dermatol (2010) 0.85
In vivo efficacy and pharmacokinetics of voriconazole in an animal model of dermatophytosis. Antimicrob Agents Chemother (2007) 0.81
Antifungal agents for common paediatric infections. Paediatr Child Health (2000) 0.79
Systemic therapy for mycoses: changing targets and changing agents. Int J Dermatol (1994) 0.75
Antifungal agents for common paediatric infections. Paediatr Child Health (2007) 0.75
Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies. J Clin Invest (1993) 2.45
The preparation and antimycotic properties of derivatives of 1-phenethylimidazole. J Med Chem (1969) 2.28
The clinical pharmacokinetics of itraconazole: an overview. Mycoses (1989) 2.27
Ketoconazole -- a new broad spectrum orally active antimycotic. Experientia (1979) 2.24
Azole resistance in Candida albicans. J Med Vet Mycol (1986) 2.17
Treatment of vaginal candidiasis with ketoconazole, a new, orally active, antimycotic. Eur J Obstet Gynecol Reprod Biol (1979) 2.01
Itraconazole, a new triazole that is orally active in aspergillosis. Antimicrob Agents Chemother (1984) 1.83
Antimycotic imidazoles. part 4. Synthesis and antifungal activity of ketoconazole, a new potent orally active broad-spectrum antifungal agent. J Med Chem (1979) 1.78
The influence of gastric acidity on the bio-availability of ketoconazole. J Antimicrob Chemother (1980) 1.68
Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models. Rev Infect Dis (1987) 1.64
Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect. Kidney Int (1994) 1.55
Promotion of pseudomycelium formation of Candida albicans in culture: a morphological study of the effects of miconazole and ketoconazole. Postgrad Med J (1979) 1.47
In vitro activities of 10 antifungal drugs against 508 dermatophyte strains. Antimicrob Agents Chemother (2001) 1.44
[Signet-ring cell colorectal carcinoma. Study of 2 cases]. Rev Esp Enferm Dig (1991) 1.39
Antimycotic azoles. 7. Synthesis and antifungal properties of a series of novel triazol-3-ones. J Med Chem (1984) 1.27
Itraconazole in the treatment of chromoblastomycosis due to Fonsecaea pedrosoi. Int J Dermatol (1992) 1.20
Ketoconazole in experimental candidosis. Rev Infect Dis (1981) 1.19
The pharmacokinetics of ketoconazole in severely immunocompromised patients. J Antimicrob Chemother (1982) 1.17
The antifungal activity of ketoconazole. Am J Med (1983) 1.15
Immunohistochemical identification of Penicillium marneffei by monoclonal antibody. Int J Dermatol (1992) 1.09
Antimycotic azoles. 6. Synthesis and antifungal properties of terconazole, a novel triazole ketal. J Med Chem (1983) 1.07
The types of drugs used by HIV-infected injection drug users in a multistate surveillance project: implications for intervention. Am J Public Health (1994) 1.07
Incidence and clinical impact of fluoroquinolone-resistant Escherichia coli in the faecal flora of cancer patients treated with high dose chemotherapy and ciprofloxacin prophylaxis. J Antimicrob Chemother (1999) 1.06
The interaction of miconazole and ketoconazole with lipids. Biochem Pharmacol (1982) 1.06
A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris. Acta Derm Venereol (2002) 1.01
Experimental systemic dermatophytosis. J Invest Dermatol (1984) 1.01
The activity of ketoconazole in clinical isolates of candida albicans cultured in a mycelium promoting medium. Mykosen (1981) 1.01
Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Comparison with neutrophil and mast cell granule proteins. Am J Pathol (1996) 1.01
Posttreatment itraconazole levels in the nail. New implications for treatment in onychomycosis. J Am Acad Dermatol (1992) 1.00
Talc granulomatosis. A differential diagnosis of interstitial lung disease in HIV patients. Chest (2000) 0.99
Culture media for the study of the effects of azole derivatives on germ tube formation and hyphal growth of C. albicans. Mykosen (1986) 0.98
Granuloma faciale entirely in an extrafacial location. Br J Dermatol (1997) 0.92
Recurrent oral blood blisters. Arch Dermatol (1999) 0.91
Oral treatment with ketoconazole in systemic candidosis of guinea-pigs: microbiology, hematology and histopathology. Sabouraudia (1985) 0.91
Lymphoepithelioma-like carcinoma of the skin. Clin Exp Dermatol (1993) 0.91
Extended-schedule dose-dense temozolomide in refractory gliomas. J Neurooncol (2009) 0.90
Experimental cutaneous Candida albicans infection in guinea-pigs. Sabouraudia (1971) 0.89
Taxol-induced acral erythema. Dermatology (1996) 0.89
Epidemiology of tinea capitis. Med Mycol (2000) 0.88
Febrile ulceronecrotic Mucha-Habermann disease. J Am Acad Dermatol (1993) 0.87
The in-vitro antifungal spectrum of itraconazole. Mycoses (1989) 0.87
Alkaline-encrusted pyelitis/cystitis and urinary tract infection due to corynebacterium urealyticum: a new severe complication after renal transplantation. Transplant Proc (1992) 0.87
Meningitis due to Streptococcus salivarius. J Clin Microbiol (2001) 0.87
[Two cases of scalp wound colonization and respiratory tract by mycelial fungi]. Rev Iberoam Micol (2000) 0.87
No evidence for Borrelia burgdorferi infection in lesions of morphea and lichen sclerosus et atrophicus in Spain. A prospective study and literature review. Acta Derm Venereol (1997) 0.87
Larval anisakids (Nematoda: Ascaridoidea) in horse mackerel (Trachurus trachurus) from the fish market in Granada (Spain). Parasitol Res (1996) 0.87
Impact of tuberculosis on the course of HIV-infected patients with a high initial CD4 lymphocyte count. Int J Tuberc Lung Dis (2004) 0.86
Experimental zygomycosis due to Rhizopus spp. infection by various routes in guinea-pigs, rats and mice. Mycoses (1988) 0.86
p16(INK4a) gene alterations are frequent in lesions of mycosis fungoides. Am J Pathol (2000) 0.86
Nosocomial infection by Rhizomucor pusillus in a clinical haematology unit. J Hosp Infect (1983) 0.85
Structural degeneration of Aspergillus fumigatus after exposure to saperconazole. J Med Vet Mycol (1989) 0.84
Epidemiology of Candida albicans isolates from heroin addicts analysed by DNA typing. Med Mycol (1998) 0.84
Role of animal and human pharmacology in antifungal drug design. Ann N Y Acad Sci (1988) 0.84
Cutaneous lesions in patients with visceral leishmaniasis and HIV infection. J Infect (1997) 0.84
Verrucous carcinoma in association with hypertrophic lichen planus. Clin Exp Dermatol (1997) 0.84
Therapeutic efficacy of itraconazole in systemic candidosis in guinea pigs. Chemotherapy (1987) 0.83
Larval anisakids (Nematoda:Ascaridoidea) in horse mackerel (Trachurus trachurus) from the fish market in Granada, Spain. Parasitol Res (1996) 0.83
Cholesterol embolism to the skin. Clin Exp Dermatol (1992) 0.82
Terconazole - a new broad-spectrum antifungal. Chemotherapy (1983) 0.82
Rate of infection and of reinfection by Echinococcus granulosus in rural dogs of the province of Rio Negro, Argentina. Vet Parasitol (2000) 0.82
Oral involvement in mycosis fungoides: report of two cases and a literature review. Acta Derm Venereol (2001) 0.81
In vitro activity of enilconazole against Aspergillus spp. and its fungicidal efficacy in a smoke generator against Aspergillus fumigatus. Mycoses (1988) 0.81
Allergic contact dermatitis from a bleaching cream. Am J Contact Dermat (2001) 0.81
Antifungal activity of enilconazole on experimental Aspergillosis in chickens. Avian Dis (1983) 0.81
[A topical solution of 40% idoxuridine in dimethyl sulfoxide compared to oral acyclovir in the treatment of herpes zoster. A double-blind multicenter clinical trial]. Med Clin (Barc) (1992) 0.81
Granuloma faciale mimicking rhinophyma: response to clofazimine. Acta Derm Venereol (2000) 0.81
Oral itraconazole versus topical bifonazole treatment in experimental dermatophytosis. Mycoses (1993) 0.80
Treatment of vaginal candidosis with oral ketoconazole. Eur J Obstet Gynecol Reprod Biol (1983) 0.80
Anticandidal activities of terconazole, a broad-spectrum antimycotic. Antimicrob Agents Chemother (1986) 0.80
Histopathology of experimental systemic candidosis in guinea-pigs. Sabouraudia (1984) 0.80
Experimental cryptococcosis: dissemination of Cryptococcus neoformans and dermotropism in guinea-pigs. Mykosen (1986) 0.80
The activity of ketoconazole and itraconazole against Aspergillus fumigatus in mixed cultures with macrophages or leukocytes. Mykosen (1986) 0.79
Necrotic livedo reticularis, multiple cholesterol emboli and ANCA. J Eur Acad Dermatol Venereol (2003) 0.78
Treatment of candidal vaginitis with miconazole, a new broad-spectrum antimycotic. Changes in microbiology, vaginal pH and cytology. Arzneimittelforschung (1973) 0.78
Animal models for dermatomycotic infections. Curr Top Med Mycol (1989) 0.78
Vapour phase activity of imazalil. Chemotherapy (1981) 0.78
Cutaneous and hepatic granulomas in a young woman with common variable immunodeficiency. Br J Dermatol (1999) 0.77
Disseminated verruciform xanthoma. Br J Dermatol (2004) 0.77
Onychomycosis caused by Microsporum canis: treatment with itraconazole. J Am Acad Dermatol (1995) 0.77
Febrile ulceronecrotic pityriasis lichenoides et varioliformis acuta with atypical cells. Int J Dermatol (2003) 0.77
Aggressive granulomatous mycosis fungoides with clinical pulmonary and thyroid involvement. Br J Dermatol (2000) 0.77
Effects of morphine on the pituitary-thyroid axis: morphological and analytical studies. Funct Dev Morphol (1991) 0.77
Ceftriaxone plus once daily aminoglycoside with filgrastim for treatment of febrile neutropenia: early hospital discharge vs. Standard In-patient care. Chemotherapy (2000) 0.77
Imaging of systemic Candida albicans infections with a radioiodinated monoclonal antibody: experimental study in the guinea pig. Int J Rad Appl Instrum B (1991) 0.76
Prevalence of undetected tinea capitis in a prospective school survey in Madrid: emergence of new causative fungi. Br J Dermatol (1998) 0.76
Immunomodulation and antifungal therapy of experimental invasive candidosis, histoplasmosis and aspergillosis: recent advances and concepts. J Med Vet Mycol (1992) 0.76
Azelastine tablets in the treatment of chronic idiopathic urticaria. Phase iii, randomised, double-blind, placebo and active controlled multicentric clinical trial. Skin Pharmacol Appl Skin Physiol (2001) 0.76
Incontinentia pigmenti: a case with an unusual course. Pediatr Dermatol (1997) 0.76
Primary cutaneous cryptococcosis. Dermatologica (1985) 0.76
Bilogical and toxicological properties of econazole, a broad-spectrum antimycotic. Arzneimittelforschung (1975) 0.76
Centroblastic transformation of chronic lymphocytic leukaemia with primary skin involvement--cutaneous presentation of Richter's syndrome. Clin Exp Dermatol (1993) 0.76
Arrested development of Ostertagia ostertagi: effect of the exposure of infective larvae to natural spring conditions of the humid pampa (Argentina). Vet Parasitol (2005) 0.76
Experimental aspergillosis in guinea pigs: influence of itraconazole on fungaemia and invasive fungal growth. Mycoses (1995) 0.75
Epidermal changes are not unusual in lupus erythematosus profundus. Int J Dermatol (1996) 0.75
Repositioning posterior chamber IOLs. J Cataract Refract Surg (1992) 0.75
Ketoconazole 2% emulsion in the treatment of seborrheic dermatitis. Int J Dermatol (1991) 0.75
1-(1-indanyl)- and 1-(1-tetralyl)imidazole-5-carboxylate esters, a novel type of antifungal agents. J Med Chem (1967) 0.75
[Problems found in the isolation of mycelial fungi (Fusarium solani) from blood culture (Bacter NR-860)]. Enferm Infecc Microbiol Clin (1993) 0.75